ArticleFrontiers in endocrinology2024
Utilizing the renal and vertebral contours as landmarks for right adrenal vein localization in primary aldosteronism: a retrospective analysis of 310 cases.
Article in Frontiers in endocrinology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Success Rate of Adrenal Venous Sampling and the Location of Right Adrenal Vein Orifice: A Retrospective Study.Journal of clinical hypertension (Greenwich, Conn.) · 2026Article
- Primary Hyperaldosteronism: Epidemiology, Diagnosis, and Clinical Associations.Epidemiologia (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Adrenal Vein Sampling (AVS) is the gold standard for categorizing primary aldosteronism (PA). However, catheterization of the right adrenal vein (RAV) can be technically challenging. This study aimed to investigate the validity of the right renal vertebral contour as fluoroscopic landmarks to help RAV orifice localization during AVS. Methods: Imaging data of 310 PA patients were retrospectively analyzed. Patients were divided into Normal, Overweight, and Obese group based on their body mass index (BMI). A novel Renal-Vertebral-Angle (R-V-A) model was employed to delineate the distribution of the RAV orifice. This model concerned a cruciate cross formed by the upper edge of the right renal and the right edge of vertebral contour under fluoroscopy. The area within a 2 cm×2 cm square in the left upper quadrant of this cross was defined as the R-V-A. The success rate of AVS was compared across different BMI groups, as well as the differences in the distribution of the RAV orifice within the R-V-A. Results: Successful RAV sampling was achieved in 270 cases, while the success rate of RAV sampling was found to be lower in the Obese group. The majority of the RAV orifices were located within the R-V-A region (249/270, 92.2%). There was no significant difference in the distribution of RAV orifices across the BMI groups (Normal vs. Overweight vs. Obese: 92.2% vs. 91.9% vs. 93.3%, Conclusion: The R-V-A model could be utilized as an anatomical landmark for the RAV orifice localization on fluoroscopy, that might help to narrow down the exploration range for RAV catheterization, and might offer beneficial assistance in enhancing the success rate for AVS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.